Skp2 p45 Inhibitors

Common Skp2 p45 Inhibitors include, but are not limited to MLN 4924 CAS 905579-51-3, Cyclopamine CAS 4449-51-8, Rapamycin CAS 53123-88-9, LY 294002 CAS 154447-36-6 and Nutlin-3 CAS 548472-68-0.

Skp2 p45, commonly referred to as Skp2, is a component of the SCF (Skp1-Cul1-F-box) E3 ubiquitin ligase complex. Skp2 plays a pivotal role in the cell cycle, especially in the G1-S phase transition. It targets specific proteins for ubiquitination, marking them for subsequent degradation by the 26S proteasome. One of the well-known targets of Skp2 is the cyclin-dependent kinase inhibitor p27^Kip1. By promoting the degradation of p27^Kip1, Skp2 facilitates cell cycle progression. In addition to its role in the cell cycle, Skp2 has been implicated in various cellular processes, including apoptosis, metabolism, and cellular senescence. The tight regulation of Skp2 is crucial for maintaining cellular homeostasis, and its dysregulation has been observed in numerous pathological conditions.

Skp2 p45 inhibitors are chemical compounds designed to modulate the activity of Skp2, predominantly by reducing its function. These inhibitors may act by directly binding to Skp2, thereby preventing it from interacting with its substrate proteins or other components of the SCF complex. Alternatively, they might obstruct Skp2's ability to recruit the E2 ubiquitin-conjugating enzyme, which is essential for the ubiquitination process. Another mechanism through which these inhibitors might function is by stabilizing the proteins that are usually targeted by Skp2 for degradation, like p27^Kip1. The identification and study of Skp2 p45 inhibitors are crucial for understanding the intricate regulatory networks in which Skp2 is involved. Given Skp2's central role in cellular processes, these inhibitors provide an essential tool for researchers aiming to decipher the complexities of cell cycle regulation and other Skp2-associated cellular functions.